Browse EV MemProt Atlas
- Frequency:
- literature support frequency.
- EVMP score:
annotation confidence score.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| SC16B | Q96JE7 | Protein transport protein Sec16B (Leucine zipper transcription regulator 2) (Regucalcin gene promoter region-related protein p117) (RGPR-p117) (SEC16 homolog B) | Predicted intracellular proteins | Fusion and delivery mediationMetabolism mediation | 1 | 0.50 | ||||
| SC5A1 | P13866 | Sodium/glucose cotransporter 1 (Na(+)/glucose cotransporter 1) (High affinity sodium-glucose cotransporter) (Solute carrier family 5 member 1) | Disease related genesFDA approved drug targetsHuman disease related genesMetabolic proteinsPlasma proteinsPredicted membrane proteinsTransporters | 14 | Clinical-translation mediationFusion and delivery mediation | 1 | 0.50 | |||
| SC5A3 | P53794 | Sodium/myo-inositol cotransporter (Na(+)/myo-inositol cotransporter) (Sodium/myo-inositol transporter 1) (SMIT1) (Solute carrier family 5 member 3) | 12 | Fusion and delivery mediationImmune mediationMetabolism mediation | 1 | 0.50 | ||||
| SC5A6 | Q9Y289 | Sodium-dependent multivitamin transporter (Na(+)-dependent multivitamin transporter) (hSMVT) (Solute carrier family 5 member 6) | Disease related genesMetabolic proteinsPlasma proteinsPotential drug targetsPredicted intracellular proteinsPredicted membrane proteinsTransporters | 13 | Substance abuse | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 1 | 0.50 | ||
| SC5AC | Q1EHB4 | Sodium-coupled monocarboxylate transporter 2 (Electroneutral sodium monocarboxylate cotransporter) (Low-affinity sodium-lactate cotransporter) (Solute carrier family 5 member 12) | Metabolic proteinsPredicted membrane proteinsTransporters | 13 | Fusion and delivery mediation | 1 | 0.50 | |||
| SCN1A | P35498 | Sodium channel protein type 1 subunit alpha (Sodium channel protein brain I subunit alpha) (Sodium channel protein type I subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.1) | 24 | Fusion and delivery mediation | 1 | 0.50 | ||||
| SCN5A | Q14524 | Sodium channel protein type 5 subunit alpha (Sodium channel protein cardiac muscle subunit alpha) (Sodium channel protein type V subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.5) (hH1) | 24 | Abnormal micturitionAngina pectorisBacterial infectionCardiac arrhythmiaCorneal diseaseCoughDissociative neurological symptom disorderEpilepsy/seizureGenetic cardiac arrhythmiaMigrainePainSolid tumour/cancerVentricular tachyarrhythmia | Clinical-translation mediationFusion and delivery mediation | 1 | 0.50 | |||
| SCN8A | Q9UQD0 | Sodium channel protein type 8 subunit alpha (Sodium channel protein type VIII subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.6) | 24 | Epilepsy/seizureEpileptic encephalopathy | Clinical-translation mediationFusion and delivery mediation | 1 | 0.50 | |||
| SCN9A | Q15858 | Sodium channel protein type 9 subunit alpha (Neuroendocrine sodium channel) (hNE-Na) (Peripheral sodium channel 1) (PN1) (Sodium channel protein type IX subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.7) | Disease related genesFDA approved drug targetsHuman disease related genesMetabolic proteinsPredicted membrane proteinsTransportersVoltage-gated ion channels | 24 | AsthmaBipolar disorderChronic painDissociative neurological symptom disorderExtremities vasodilatationGeneral pain disorderOsteoarthritisPainRadiculopathyTrigeminal nerve disorder | Clinical-translation mediationFusion and delivery mediation | 1 | 0.50 | ||
| SCNND | P51172 | Epithelial sodium channel subunit delta (Delta-ENaC) (ENaCD) (Epithelial Na(+) channel subunit delta) (Amiloride-sensitive sodium channel subunit delta) (Delta-NaCH) (Nonvoltage-gated sodium channel 1 subunit delta) (SCNED) | FDA approved drug targetsMetabolic proteinsPredicted intracellular proteinsPredicted membrane proteinsTransporters | 2 | Clinical-translation mediationFusion and delivery mediation | 1 | 0.50 | |||
| SDC2 | P34741 | Syndecan-2 (SYND2) (Fibroglycan) (Heparan sulfate proteoglycan core protein) (HSPG) (CD antigen CD362) | CD markersPredicted membrane proteins | 1 | Clinical-translation mediationImmune mediationMetabolism mediation | 1 | 0.50 | |||
| SEM4D | Q92854 | Semaphorin-4D (A8) (BB18) (GR3) (CD antigen CD100) | CD markersPlasma proteinsPredicted intracellular proteinsPredicted membrane proteins | 1 | Choreiform disorderLung cancerMetastatic lymph node neoplasmMultiple sclerosis | Adhesion and uptake mediationClinical-translation mediationReceptor-signaling mediation | 1 | 0.50 | ||
| SERC5 | Q86VE9 | Serine incorporator 5 | Predicted membrane proteinsTransporters | 9 | Fusion and delivery mediationMetabolism mediation | 1 | 0.50 | |||
| SHSA6 | Q6ZSJ9 | Protein shisa-6 | Predicted membrane proteinsTransporters | 1 | Fusion and delivery mediationReceptor-signaling mediation | 1 | 0.50 | |||
| SIA8E | O15466 | Alpha-2,8-sialyltransferase 8E (EC 2.4.99.-) (Sialyltransferase 8E) (SIAT8-E) (Sialyltransferase St8Sia V) (ST8SiaV) | Metabolic proteinsPredicted membrane proteins | 1 | Metabolism mediation | 1 | 0.50 | |||
| SIGL7 | Q9Y286 | Sialic acid-binding Ig-like lectin 7 (Siglec-7) (Adhesion inhibitory receptor molecule 1) (AIRM-1) (CDw328) (D-siglec) (QA79 membrane protein) (p75) (CD antigen CD328) | CD markersPredicted intracellular proteinsPredicted membrane proteins | 1 | Immune mediation | 1 | 0.50 | |||
| SKAP1 | Q86WV1 | Src kinase-associated phosphoprotein 1 (Src family-associated phosphoprotein 1) (Src kinase-associated phosphoprotein of 55 kDa) (SKAP-55) (pp55) | Predicted intracellular proteins | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | ||||
| SL9A3 | P48764 | Sodium/hydrogen exchanger 3 (Na(+)/H(+) exchanger 3) (NHE-3) (Solute carrier family 9 member 3) | Disease related genesFDA approved drug targetsHuman disease related genesMetabolic proteinsPredicted membrane proteinsTransporters | 13 | Angina pectorisBreathing abnormalityCardiac arrhythmiaChronic kidney diseaseGenetic cardiac arrhythmiaIrritable bowel syndromeUrinary system disease | Clinical-translation mediationFusion and delivery mediation | 1 | 0.50 | ||
| SL9A4 | Q6AI14 | Sodium/hydrogen exchanger 4 (Na(+)/H(+) exchanger 4) (NHE-4) (Solute carrier family 9 member 4) | Metabolic proteinsPredicted membrane proteinsTransporters | 10 | Fusion and delivery mediation | 1 | 0.50 | |||
| SMO | Q99835 | Protein smoothened (Protein Gx) | Cancer-related genesDisease related genesFDA approved drug targetsG-protein coupled receptorsHuman disease related genesPlasma proteinsPredicted membrane proteinsTransporters | 7 | Basal cell carcinomaBrain cancerChronic myelomonocytic leukaemiaOvarian cancerSkin cancerSolid tumour/cancer | Clinical-translation mediationFusion and delivery mediationMetabolism mediationReceptor-signaling mediation | 1 | 0.50 | ||
| SNAG | Q99747 | Gamma-soluble NSF attachment protein (SNAP-gamma) (N-ethylmaleimide-sensitive factor attachment protein gamma) | Essential proteinsPredicted intracellular proteins | Fusion and delivery mediationMetabolism mediation | 1 | 0.50 | ||||
| SNP23 | O00161 | Synaptosomal-associated protein 23 (SNAP-23) (Vesicle-membrane fusion protein SNAP-23) | Predicted intracellular proteinsPredicted membrane proteinsTransporters | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediationImmune mediationReceptor-signaling mediation | 1 | 0.50 | ||||
| SNP25 | P60880 | Synaptosomal-associated protein 25 (SNAP-25) (Super protein) (SUP) (Synaptosomal-associated 25 kDa protein) | Disease related genesFDA approved drug targetsHuman disease related genesPredicted intracellular proteinsTransporters | Eyelid inflammatory/movement disorder | Clinical-translation mediationFusion and delivery mediationImmune mediationMetabolism mediationReceptor-signaling mediation | 1 | 0.50 | |||
| SNTB2 | Q13425 | Beta-2-syntrophin (59 kDa dystrophin-associated protein A1 basic component 2) (Syntrophin-3) (SNT3) (Syntrophin-like) (SNTL) | Adhesion and uptake mediationFusion and delivery mediation | 1 | 0.50 | |||||
| SNTG2 | Q9NY99 | Gamma-2-syntrophin (G2SYN) (Syntrophin-5) (SYN5) | Predicted intracellular proteins | Other mediation | 1 | 0.50 |